(Q58255428)

https://api.crossref.org/works/10.1080%2F02687030050205705

Hypertension and risk of stroke recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The pharmacotherapy of aphasia: Historical perspective and directions for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Diaspirin cross-linked hemoglobin improves neurological outcome following reversible but not irreversible CNS ischemia in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Pharmacological reduction of electrophysiological diaschisis after photothrombotic ischemia in rat neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

d-Amphetamine in Elderly Patients Refractory to Rehabilitation Procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

A randomized efficacy trial of citicoline in patients with acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Effects of piracetam on N-methyl-D-aspartate receptor properties in the aged mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Focal cerebral ischemia in rats: effect of hemodilution with alpha-alpha cross-linked hemoglobin on CBF

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The Canadian Neurological Scale: a preliminary study in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The token test: A sensitive test to detect receptive disturbances in aphasics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Considerations in the design of clinical trials of neuroprotective therapy in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Duration of neuroprotective treatment for ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The response of GABAergic and cholinergic neurons to transient cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Anatomic basis of transcortical motor aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The pharmacotherapy of focal cortical ischaemia in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Rodent models of stroke limitations. What can we learn from recent clinical trials of thrombolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Bromocriptine treatment of nonfluent aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

21 January 2018

Neuroprotective therapy

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The performance test of activities of daily living

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Cerestat and other NMDA antagonists in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Thrombolysis for acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a gamma-aminobutyric acid agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Acetylcholine and experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Stroke and acute Myocardial Infarction in the Thrombolytic era: Clinical correlates and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Tissue injury by free radicals and other toxic oxygen metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

An open-label trial of bromocriptine in nonfluent aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The effect of hyperbaric oxygen on the mental and verbal ability of stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The biologic basis for the treatment of acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The current and future use of thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Pharmacotherapy of aphasia. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Clinical potential for the use of neuroprotective agents. A brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

MEASUREMENT OF MAXIMAL PERMISSIBLE CEREBRAL ISCHEMIA AND A STUDY OF ITS PHARMACOLOGIC PROLONGATION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Pharmacological actions of a new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Aphasia: effect of intravenous sodium amytal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Focal cerebral ischemia in rats: effect of hemodilution with alpha-alpha cross-linked hemoglobin on brain injury and edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Modulation of GABAA and glycine receptors by chlormethiazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Restoration of speech in severe aphasia by intravenous and oral priscol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Sodium amytal in treatment of aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Pharmacological approaches to the treatment of aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Synaptic activity mediates death of hypoxic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

The effect of hyperbaric oxygen on communication function in adults with aphasia secondary to stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705

THE EFFECT OF MEPROBAMATE ON RECOVERY FROM APHASIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02687030050205705